Higher heart rate variability of smokers after acute myocardial infarction

International Journal of Cardiology

Volumn 68, Issue 2, 1999, Pages 165-169

  Nishiue, Takashi ^a   Tsuji, Hisako ^a   Tokunaga, Satoshi ^a   Tamura, Koji ^a   Yamamoto, Yoshihiro ^a   Inada, Mitsuo ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cigarette smoking; Heart rate variability; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; SMOKING;

EID: 0033611730     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00347-7     Document Type: Article

References (33)

1. Wilhelmsson C., Vedin J.A., Elmfeldt D., Tibblin G., Wilhelmsen L. Smoking and myocardial infarction. Lancet. 1:1975;415-420.
2. Voors A.A., van Brussel B.L., Plokker H.W.T.et al. Smoking and cardiac events after venous coronary bypass surgery: a 15-year follow up study. Circulation. 93:1996;42-47.
3. The Cardiac Arrhythmia Suppression Trial (CAST) investigators. Smoking cessation and arrhythmic death: the CAST experience. J Am Coll Cardiol 1995;26:1287-92.
4. Hasdai D., Garrat K.N., Grill D.E., Lerman A., Holmes D.R. Jr. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. New Engl J Med. 336:1997;755-761.
5. Barbash GI, White HD, Moban M, Diaz R, Hampton JR for the investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Circulation 1993;87:53-8.
6. Kelley T.L., Gilpin E., Ahnve S., Henning H., Ross J. Jr. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J. 110:1985;535-541.
7. Molstad P. First myocardial infarction in smokers. Eur Heart J. 12:1991;753-759.
8. The TIMI investigators. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Circulation 1992;85:1254-64.
9. Grines C.L., Topol E.J., O'Neill W.W., George B.S., Kereiakes D., Phillips H.R. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation. 91:1995;298-303.
10. The GUSTO-I investigators. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the 'Smoker's Paradox' GUSTO-I Trial, with angiographic insights. J Am Coll Caldiol 1995;26:1222-29.
11. Gottlieb S, Boyco V, Zarger D et al. for the Israel Thrombolytic Survey Group. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israel Thrombolytic National Survey). J Am Coll Caldiol 1996;28:1506-13.
12. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Barger A.C., Cohren R.J. Power spectrum analysis of heart rate fraction: a quantitative probe of beat to beat cardiovascular control. Science. 213:1981;220-222.
13. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ, the Multicenter Post-infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-62.
14. Bigger J.T. Jr., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Kleiger R.E., Rottman J.N. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 85:1992;164-171.
15. Tsuji H., Venditti F.J., Manders E.S., Evans J.C., Larson M.G., Feldman C.L. Determinants of heart rate variability. J Am Coll Cardiol. 28:1996;1539-1546.
16. Hayano J., Yamada M., Sakakibara Y. Short- and long-term effects of cigarette smoking on heart rate variability. Am J Cardiol. 65:1990;84-88.
17. Stein P.K., Rottman J.N., Kleiger R.E. Effect of 21 mg transdermal nicotine patches and smoking cessation on heart rate variability. Am J Cardiol. 77:1996;701-705.
18. Bigger J.T. Jr., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Shneider W.J., Stein P.K. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation. 91:1995;1936-1943.
19. Casolo G.C., Stroder P., Signorini C., Calzolari F., Zucchini M., Balli E. Heart rate variability during the acute phase of myocardial infarction. Circulation. 85:1992;2073-2079.
20. Saul J.P., Arai Y., Berger R.D., Lilly L.S., Colucci W.S., Cohen R.J. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol. 61:1988;1292-1299.
21. Hermosillo A.G., Donardo M., Casanova J.M., Ponse de Leon S., Cossio J., Kersenovich S. Influence of infarct-related artery patency on the indexes of parasympathetic activity and prevalence of late potentials in survivors of acute myocardial infarction. J Am Coll Cardiol. 22:1993;695-706.
22. Pedretti B.E.E., Colombo E., Braga S.S., Caru B. Effect of thrombolysis on heart rate variability and life-threatening ventricular arrhythmias in survivors of acute myocardial infarction. J Am Coll Cardiol. 23:1994;19-26.
23. Weise F, Heidenreich. A non-invasive approach to cardiac autonomic neuropathy in patients with diabetes mellitus. Clin Physiol 1990;10:137-45.
24. Malpas S.C., Maling T.J.B. Heart rate variability and cardiac autonomic function in diabetes. Diabetes. 39:1990;1177-1181.
25. Tuininga Y.S., Crijins H.J.G.M., Brouwer J., van den Berg M.P., Man in't Veld A.J., Mulder G. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance task, physiological exercise, and daily life in stable postinfarct patients. Circulation. 92:1995;3415-3423.
26. Adamson P.B., Huang M.H., Vanoli E., Foreman R.D., Schwartz P.J., Hull S.S. Jr. Unexpected interaction between β-adrenergic blockade and heart rate variability before and after myocardial infarction. Circulation. 90:1994;976-982.
27. Sandrone G., Mortara A., Torzillo D., La Rovere M.T., Malliani A., Lombardi F. Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol. 74:1994;340-345.
28. SAS Institute Inc: SAS/Stat User's Guide, version 6, 4th ed., Vol. 2. Cray, NC: SAS Institute Inc., 1989:846 (The REG Procedure, 1351-1456).
29. SAS Institute Inc: SAS/Stat User's Guide, version 6, 4th ed., Vol. 2. Cray, NC: SAS Institute Inc., 1989:846 (The REG Procedure, 1351-1456).
30. Ward K.D., Garvey A.J., Bliss R.E. Evidence of transient heart rate change after smoking cessation. Psychopharmacology. 106:1992;337-340.
31. Persicp A.M. Persistent decrease in heart rate after smoking cessation: a 1-year follow-up study. Psychopharmacology. 106:1992;397-400.
32. Butler G.C., Naughton M.T., Rahman M.A., Bradley T.D., Floras J.S. Continuous positive airway pressure increases heart rate variability in congestive heart failure. J Am Coll Cardiol. 25:1995;672-679.
33. Ahmed M.W., Kadish A.H., Parker M.A., Goldberger J.J. Effect of physiologic and pharmacologic adrenergic stimulation on heart rate variability. J Am Coll Cardiol. 24:1994;1082-1090.